Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
371
-
Total 13F shares, excl. options
-
79.9M
-
Shares change
-
+5.93M
-
Total reported value, excl. options
-
$4.76B
-
Value change
-
+$360M
-
Put/Call ratio
-
0.04
-
Number of buys
-
190
-
Number of sells
-
-160
-
Price
-
$59.54
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2023
442 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2023.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 371 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.9M shares
of 115M outstanding shares and own 69.33% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.51M shares), BlackRock Inc. (7.36M shares), JANUS HENDERSON GROUP PLC (7.09M shares), NUANCE INVESTMENTS, LLC (2.65M shares), STATE STREET CORP (2.37M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.27M shares), WELLINGTON MANAGEMENT GROUP LLP (2.22M shares), JPMORGAN CHASE & CO (1.9M shares), Champlain Investment Partners, LLC (1.7M shares), and GW&K Investment Management, LLC (1.69M shares).
This table shows the top 371 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.